FDA Drug recall D-0141-2024
ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131…
- FDA Drug
- Class II
- completed
- Published 2023-12-13
On 2023-12-13 the FDA classified a Class II recall of ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131… by Wells Pharma, citing lack of assurance of sterility.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0141-2024 |
| Classification | Class II |
| Status | completed |
| Initiated | 2023-11-22 |
| Published | 2023-12-13 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Wells Pharma |
| Distribution | PA |
Product
ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10
Reason
Lack of assurance of sterility.
Identifiers
| code_info | Lot # 11092313110#01, Exp 01/12/24 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: completed.
Other recalls by Wells Pharma
- fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg per mL), 250 mL bag, wells pharma of Hou…
FDA Drug · Class II · 2026-05-06 · Wells Pharma - fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65
FDA Drug · Class II · 2026-05-06 · Wells Pharma - Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31
FDA Drug · Class II · 2026-05-06 · Wells Pharma - fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25
FDA Drug · Class II · 2026-05-06 · Wells Pharma - fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15
FDA Drug · Class II · 2026-05-06 · Wells Pharma
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0141-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.